Nitrosamine Impurities Deadline: Are Your Products Compliant?
The FDA has made nitrosamine reduction in medication a top priority for the entire industry, with deadlines for compliance fast approaching. There is no magic bullet for this challenge, no one-size-fits-all solution. To be effective and sustainable, a mitigation strategy needs to be custom-built for a specific molecule, formulation, and microenvironment.
In this webinar, nitrosamine mitigation expert Jason Brown will walk you through a multi-pronged approach to addressing the issue head-on, and discuss potential strategies for vulnerable drug products. You will learn how to select an experienced provider of nitrosamine mitigation services and how to work with them to craft a quantified mitigation strategy created specifically to minimize nitrosamine formation. Bring your product into compliance while maintaining control of the process at every step.
Key Learning Objectives:
- The FDA's guidance on nitrosamine sets tight compliance deadlines that are quickly approaching
- Nitrosamine mitigation is a complex challenge without a simple one-size-fits-all solution
- Nitrosamine mitigation has a steep barrier of entry and demands an experienced partner to ensure compliance before the deadline
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.